IceCure Medical (ICCM)
(Delayed Data from NSDQ)
$0.74 USD
0.00 (-0.27%)
Updated Jul 3, 2024 12:49 PM ET
After-Market: $0.73 -0.01 (-1.26%) 6:18 PM ET
2-Buy of 5 2
F Value C Growth C Momentum D VGM
IceCure Medical Ltd. (ICCM) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$3.39 | $4.16 | $3.00 | 358.11% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for IceCure Medical Ltd. comes to $3.39. The forecasts range from a low of $3.00 to a high of $4.16. The average price target represents an increase of 358.11% from the last closing price of $0.74.
Analyst Price Targets (3 )
Broker Rating
IceCure Medical Ltd. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, three are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/5/2024 | H.C. Wainwright & Co. | Yi Chen | Strong Buy | Strong Buy |
5/28/2024 | Brookline Capital Markets | Kemp Dolliver | Strong Buy | Strong Buy |
2/2/2024 | Maxim Group | Anthony V Vendetti | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 3 |
Average Target Price | $3.39 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 92 of 252 |
Current Quarter EPS Est: | -0.07 |